Pfizer

PFE
27.4000.51% ( -0.140 )
Closed: Nov 20, 16:00:00 (EDT)

Valuation

Current ValuationThe current P/E ratio is 38.72, above the reasonable range, cheaper than 8.59% of the time in the past 5 years, and the industry ranks 45/255, the industry Median -0.87.

38.72xP/E
Stock price$27.40Earnings per share$0.71

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
03468102136

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
P/E ratio
Name/Symbol
JNJUSJohnson & Johnson
40.45x33.62%$651.11B
PFEUSPfizer
38.72x13.37%$156.18B
MKKGYUSMerck
31.43x--$69.28B
RDYUSDr Reddys Laboratories
41.48x10.51%$12.40B
CORTUSCorcept Therap
43.15x175.85%$6.88B
ETONUSEton Pharmaceuticals
35.20x1,282.35%$1.76B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.